Global Point-of-Care Glucose Testing Market Size study, by Product Type (Strips, Lancets & Lancing Devices, Meters), by Testing Site (Fingertip, Alternate Site Testing), by End-User (Professional Diagnostic Centers, Hospitals & Clinics, Home Care settings, Others) and Regional Forecasts 2020-2026
Global Point-of-Care Glucose Testing Market is valued approximately at USD XXX million in 2019 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2020-2026. In recent years, the demand for point-of-care glucose testing has been witnessed significant growth. Point-of-care glucose testing helps in performing effective diagnosis at the patient's bedside as compared to conventional laboratory testing. Point-of-care testing (POCT) for glucose monitoring is a valuable tool for supervising diabetic patients in outpatient settings. Further, point-of-care glucose testing devices and electronic medical records also allow sharing of test results instantly with healthcare providers. Potential operational benefits with reduced operating times, rapid decision-making capabilities, and high dependency strengthening the market growth of point-of-care glucose testing. Further, rise in the prevalence of diabetes, growing number of elderly population and increase in preference for home health care among people are the few factors responsible for high CAGR of the market over the forecast period. According to the International Diabetic Federation (IDF), the number of adults with diabetes was estimated around 415 million in 2015, and this number is projected to grow to almost 578 million by 2030, globally. Similarly, IDF also estimated that the number of diabetic patients in Europe is likely to rise from nearly 33 million in 2010 to 38 million in 2030. This, in turn, is expected to accelerate the demand for Point-of-Care Glucose Testing, thus contributing to the growth of the global market. However, accuracy issues in testing, stringent and time-consuming regulatory policies are the few factors expected to hamper the growth of the market over the forecast period of 2020-2026.
The regional analysis of global Point-of-Care Glucose Testing market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the surging prevalence of diabetes and other lifestyle disorders, increase in number of product approvals and favorable government initiatives in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to growing healthcare facilities and favorable reimbursement policies in the countries like China and India.
Major market player included in this report are:
Roche Diabetes Care
LifeScan IP Holdings, LLC.
Abbott Laboratories
Ascensia Diabetes Care
Trividia Health, Inc.
Nova Biomedical
F. Hoffmann-La Roche Ltd.
Nipro Corporation
Prodigy Diabetes Care, LLC
EKF Diagnostics
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Strips
Lancets & Lancing Devices
Meters
By Testing Site:
Fingertip
Alternate Site Testing
By End-User:
Professional Diagnostic Centers
Hospitals & Clinics
Home Care settings
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026
Target Audience of the Global Point-of-Care Glucose Testing Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The regional analysis of global Point-of-Care Glucose Testing market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the surging prevalence of diabetes and other lifestyle disorders, increase in number of product approvals and favorable government initiatives in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to growing healthcare facilities and favorable reimbursement policies in the countries like China and India.
Major market player included in this report are:
Roche Diabetes Care
LifeScan IP Holdings, LLC.
Abbott Laboratories
Ascensia Diabetes Care
Trividia Health, Inc.
Nova Biomedical
F. Hoffmann-La Roche Ltd.
Nipro Corporation
Prodigy Diabetes Care, LLC
EKF Diagnostics
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Strips
Lancets & Lancing Devices
Meters
By Testing Site:
Fingertip
Alternate Site Testing
By End-User:
Professional Diagnostic Centers
Hospitals & Clinics
Home Care settings
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026
Target Audience of the Global Point-of-Care Glucose Testing Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Million)
1.2.1. Point-of-Care Glucose Testing Market, by Region, 2018-2026 (USD Million)
1.2.2. Point-of-Care Glucose Testing Market, by Product Type, 2018-2026 (USD Million)
1.2.3. Point-of-Care Glucose Testing Market, by Testing Site, 2018-2026 (USD Million)
1.2.4. Point-of-Care Glucose Testing Market, by End-User, 2018-2026 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET DYNAMICS
3.1. Point-of-Care Glucose Testing Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE
5.1. Market Snapshot
5.2. Global Point-of-Care Glucose Testing Market by Product Type, Performance - Potential Analysis
5.3. Global Point-of-Care Glucose Testing Market Estimates & Forecasts by Product Type 2016-2026 (USD Million)
5.4. Point-of-Care Glucose Testing Market, Sub Segment Analysis
5.4.1. Strips
5.4.2. Lancets & Lancing Devices
5.4.3. Meters
CHAPTER 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, BY TESTING SITE
6.1. Market Snapshot
6.2. Global Point-of-Care Glucose Testing Market by Testing Site, Performance - Potential Analysis
6.3. Global Point-of-Care Glucose Testing Market Estimates & Forecasts by Testing Site 2016-2026 (USD Million)
6.4. Point-of-Care Glucose Testing Market, Sub Segment Analysis
6.4.1. Fingertip
6.4.2. Alternate Site Testing
CHAPTER 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, BY END-USER
7.1. Market Snapshot
7.2. Global Point-of-Care Glucose Testing Market by End-User, Performance - Potential Analysis
7.3. Global Point-of-Care Glucose Testing Market Estimates & Forecasts by End-User 2016-2026 (USD Million)
7.4. Point-of-Care Glucose Testing Market, Sub Segment Analysis
7.4.1. Professional Diagnostic Centers
7.4.2. Hospitals & Clinics
7.4.3. Home Care settings
7.4.4. Others
CHAPTER 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, REGIONAL ANALYSIS
8.1. Point-of-Care Glucose Testing Market, Regional Market Snapshot
8.2. North America Point-of-Care Glucose Testing Market
8.2.1. U.S. Point-of-Care Glucose Testing Market
8.2.1.1. Product Type breakdown estimates & forecasts, 2016-2026
8.2.1.2. Testing Site breakdown estimates & forecasts, 2016-2026
8.2.1.3. End-User breakdown estimates & forecasts, 2016-2026
8.2.2. Canada Point-of-Care Glucose Testing Market
8.3. Europe Point-of-Care Glucose Testing Market Snapshot
8.3.1. U.K. Point-of-Care Glucose Testing Market
8.3.2. Germany Point-of-Care Glucose Testing Market
8.3.3. Rest of Europe Point-of-Care Glucose Testing Market
8.4. Asia-Pacific Point-of-Care Glucose Testing Market Snapshot
8.4.1. China Point-of-Care Glucose Testing Market
8.4.2. India Point-of-Care Glucose Testing Market
8.4.3. Japan Point-of-Care Glucose Testing Market
8.4.4. Rest of Asia Pacific Point-of-Care Glucose Testing Market
8.5. Latin America Point-of-Care Glucose Testing Market Snapshot
8.5.1. Brazil Point-of-Care Glucose Testing Market
8.5.2. Mexico Point-of-Care Glucose Testing Market
8.6. Rest of The World Point-of-Care Glucose Testing Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Roche Diabetes Care
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. LifeScan IP Holdings, LLC.
9.2.3. Abbott Laboratories
9.2.4. Ascensia Diabetes Care
9.2.5. Trividia Health, Inc.
9.2.6. Nova Biomedical
9.2.7. F. Hoffmann-La Roche Ltd.
9.2.8. Nipro Corporation
9.2.9. Prodigy Diabetes Care, LLC
9.2.10. EKF Diagnostics
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Million)
1.2.1. Point-of-Care Glucose Testing Market, by Region, 2018-2026 (USD Million)
1.2.2. Point-of-Care Glucose Testing Market, by Product Type, 2018-2026 (USD Million)
1.2.3. Point-of-Care Glucose Testing Market, by Testing Site, 2018-2026 (USD Million)
1.2.4. Point-of-Care Glucose Testing Market, by End-User, 2018-2026 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET DYNAMICS
3.1. Point-of-Care Glucose Testing Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE
5.1. Market Snapshot
5.2. Global Point-of-Care Glucose Testing Market by Product Type, Performance - Potential Analysis
5.3. Global Point-of-Care Glucose Testing Market Estimates & Forecasts by Product Type 2016-2026 (USD Million)
5.4. Point-of-Care Glucose Testing Market, Sub Segment Analysis
5.4.1. Strips
5.4.2. Lancets & Lancing Devices
5.4.3. Meters
CHAPTER 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, BY TESTING SITE
6.1. Market Snapshot
6.2. Global Point-of-Care Glucose Testing Market by Testing Site, Performance - Potential Analysis
6.3. Global Point-of-Care Glucose Testing Market Estimates & Forecasts by Testing Site 2016-2026 (USD Million)
6.4. Point-of-Care Glucose Testing Market, Sub Segment Analysis
6.4.1. Fingertip
6.4.2. Alternate Site Testing
CHAPTER 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, BY END-USER
7.1. Market Snapshot
7.2. Global Point-of-Care Glucose Testing Market by End-User, Performance - Potential Analysis
7.3. Global Point-of-Care Glucose Testing Market Estimates & Forecasts by End-User 2016-2026 (USD Million)
7.4. Point-of-Care Glucose Testing Market, Sub Segment Analysis
7.4.1. Professional Diagnostic Centers
7.4.2. Hospitals & Clinics
7.4.3. Home Care settings
7.4.4. Others
CHAPTER 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, REGIONAL ANALYSIS
8.1. Point-of-Care Glucose Testing Market, Regional Market Snapshot
8.2. North America Point-of-Care Glucose Testing Market
8.2.1. U.S. Point-of-Care Glucose Testing Market
8.2.1.1. Product Type breakdown estimates & forecasts, 2016-2026
8.2.1.2. Testing Site breakdown estimates & forecasts, 2016-2026
8.2.1.3. End-User breakdown estimates & forecasts, 2016-2026
8.2.2. Canada Point-of-Care Glucose Testing Market
8.3. Europe Point-of-Care Glucose Testing Market Snapshot
8.3.1. U.K. Point-of-Care Glucose Testing Market
8.3.2. Germany Point-of-Care Glucose Testing Market
8.3.3. Rest of Europe Point-of-Care Glucose Testing Market
8.4. Asia-Pacific Point-of-Care Glucose Testing Market Snapshot
8.4.1. China Point-of-Care Glucose Testing Market
8.4.2. India Point-of-Care Glucose Testing Market
8.4.3. Japan Point-of-Care Glucose Testing Market
8.4.4. Rest of Asia Pacific Point-of-Care Glucose Testing Market
8.5. Latin America Point-of-Care Glucose Testing Market Snapshot
8.5.1. Brazil Point-of-Care Glucose Testing Market
8.5.2. Mexico Point-of-Care Glucose Testing Market
8.6. Rest of The World Point-of-Care Glucose Testing Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Roche Diabetes Care
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. LifeScan IP Holdings, LLC.
9.2.3. Abbott Laboratories
9.2.4. Ascensia Diabetes Care
9.2.5. Trividia Health, Inc.
9.2.6. Nova Biomedical
9.2.7. F. Hoffmann-La Roche Ltd.
9.2.8. Nipro Corporation
9.2.9. Prodigy Diabetes Care, LLC
9.2.10. EKF Diagnostics
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET
TABLE 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
TABLE 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY PRODUCT TYPE 2016-2026 (USD MILLION)
TABLE 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY TESTING SITE 2016-2026 (USD MILLION)
TABLE 9. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD MILLION)
TABLE 10. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 11. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 12. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 13. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 14. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 15. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 16. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 17. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 18. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 19. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 20. U.S. POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 21. U.S. POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 22. U.S. POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 23. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 24. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 25. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 26. UK POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 27. UK POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 28. UK POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 29. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 30. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 31. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 32. ROE POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 33. ROE POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 34. ROE POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 35. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 36. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 37. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 38. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 39. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 40. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 41. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 42. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 43. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 44. ROAPAC POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 45. ROAPAC POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 46. ROAPAC POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 47. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 48. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 49. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 50. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 51. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 52. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 53. ROLA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 54. ROLA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 55. ROLA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 56. ROW POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 57. ROW POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 58. ROW POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET
TABLE 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
TABLE 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY PRODUCT TYPE 2016-2026 (USD MILLION)
TABLE 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY TESTING SITE 2016-2026 (USD MILLION)
TABLE 9. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD MILLION)
TABLE 10. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 11. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 12. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 13. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 14. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 15. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 16. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 17. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 18. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 19. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 20. U.S. POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 21. U.S. POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 22. U.S. POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 23. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 24. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 25. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 26. UK POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 27. UK POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 28. UK POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 29. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 30. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 31. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 32. ROE POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 33. ROE POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 34. ROE POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 35. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 36. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 37. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 38. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 39. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 40. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 41. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 42. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 43. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 44. ROAPAC POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 45. ROAPAC POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 46. ROAPAC POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 47. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 48. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 49. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 50. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 51. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 52. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 53. ROLA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 54. ROLA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 55. ROLA POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 56. ROW POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 57. ROW POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 58. ROW POINT-OF-CARE GLUCOSE TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
LIST OF FIGURES
FIG 1. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, KEY TRENDS 2019
FIG 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, GROWTH PROSPECTS 2020-2026
FIG 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, PEST ANALYSIS
FIG 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 10. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 11. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 12. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 13. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 14. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 15. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET 2016 & 2026 (USD MILLION)
FIG 16. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET 2016 & 2026 (USD MILLION)
FIG 17. ASIA PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET 2016 & 2026 (USD MILLION)
FIG 18. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET 2016 & 2026 (USD MILLION)
FIG 19. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, COMPANY MARKET SHARE ANALYSIS (2019)
COMPANIES MENTIONED
Roche Diabetes Care
LifeScan IP Holdings, LLC.
Abbott Laboratories
Ascensia Diabetes Care
Trividia Health, Inc.
Nova Biomedical
F. Hoffmann-La Roche Ltd.
Nipro Corporation
Prodigy Diabetes Care, LLC
EKF Diagnostics
FIG 1. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, KEY TRENDS 2019
FIG 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, GROWTH PROSPECTS 2020-2026
FIG 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, PEST ANALYSIS
FIG 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 10. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 11. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 12. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 13. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 14. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 15. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET 2016 & 2026 (USD MILLION)
FIG 16. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET 2016 & 2026 (USD MILLION)
FIG 17. ASIA PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET 2016 & 2026 (USD MILLION)
FIG 18. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET 2016 & 2026 (USD MILLION)
FIG 19. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, COMPANY MARKET SHARE ANALYSIS (2019)
COMPANIES MENTIONED
Roche Diabetes Care
LifeScan IP Holdings, LLC.
Abbott Laboratories
Ascensia Diabetes Care
Trividia Health, Inc.
Nova Biomedical
F. Hoffmann-La Roche Ltd.
Nipro Corporation
Prodigy Diabetes Care, LLC
EKF Diagnostics
